Claire Hazelgrove MP: written questions
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Read what this MP said, asked and contributed in Parliament.
11 published records · newest first.
Written questions
Respiratory Syncytial Virus: VaccinationDepartment of Health and Social CareTabled 29 Jun 2026AnsweredUIN 14213More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of eligibility criteria for the Respiratory Syncytial Virus vaccination programme for adults with serious underlying respiratory conditions, including pu
Answer: In line with independent expert advice from the Joint Committee on Vaccination and Immunisation (JCVI), year-round respiratory syncytial virus (RSV) vaccination programmes were introduced in England in September 2024 to protect infants, via maternal vacci...
Answered 7 Jul 2026
Original Parliament recordSurrogacyDepartment of Health and Social CareTabled 22 Jun 2026AnsweredUIN 11944More
Question: To ask the Secretary of State for Health and Social Care, what his Department's planned timetable is for publishing a response to the Law Commission’s 2023 report on surrogacy; and what steps it is taking to address concerns about the impact of potential
Answer: The Government will respond to the Law Commission’s legislative proposals on surrogacy as time allows.The commission’s report and recommendations cover issues around legal parenthood and parental responsibility in surrogacy. These will be considered caref...
Answered 1 Jul 2026
Original Parliament recordParkinson's Disease: PrescriptionsDepartment of Health and Social CareTabled 18 Jun 2026AnsweredUIN 11335More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of current prescription charging policy on people diagnosed with Parkinson’s disease under the age of 60.
Answer: I refer the Hon. Member to the answer I gave to the Hon. Member for Mid Dorset and North Poole on 1 June 2026 to Question 2931.
Answered 29 Jun 2026
Original Parliament recordHydrocortisoneDepartment of Health and Social CareTabled 18 Jun 2026AnsweredUIN 11332More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support patients affected by the discontinuation of hydrocortisone sodium phosphate 100mg/1ml solution in the UK, including ensuring continued access to appro
Answer: I refer the Hon. Member to the answer I gave to the Hon. Member for Wokingham on 22 May 2026 to Question 2576.
Answered 29 Jun 2026
Original Parliament recordEndometriosis: Health ServicesDepartment of Health and Social CareTabled 18 Jun 2026AnsweredUIN 11331More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that patients with endometriosis are able to access timely NHS surgical treatment, and to reduce the need for patients to seek private care.
Answer: We are committed to returning to the National Health Service constitutional standard that 92% of patients wait no longer than 18 weeks from referral to consultant-led treatment by March 2029, including for gynaecology which covers endometriosis treatment....
Answered 26 Jun 2026
Original Parliament recordPharmacyDepartment of Health and Social CareTabled 18 May 2026AnsweredUIN 2520More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that self employed locum pharmacists are paid in a timely manner for services delivered within NHS contracted pharmacies; and whether he plans to intro
Answer: Responsibility for agreeing contractual terms and for ensuring payment to self-employed locum pharmacists rests with the retail pharmacy businesses that deliver National Health Service pharmaceutical services.Where locum pharmacists have trouble recoverin...
Answered 27 May 2026
Original Parliament recordPregnancy: ScreeningDepartment of Health and Social CareTabled 20 Apr 2026AnsweredUIN 128454More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the consistency and effectiveness of (a) antenatal screening in detecting fetal cardiac conditions and (b) the efficacy of the Fetal anomaly screening pro
Answer: The Government recognises how worrying heart health can be for the families of babies and children. The NHS Fetal Anomaly Screening Programme (FASP) recommends the offer of an ultrasound scan which is performed between 18+0 to 20+6 weeks to screen for 11 ...
Answered 27 Apr 2026
Original Parliament recordPrivate Patients: ComplaintsDepartment of Health and Social CareTabled 10 Apr 2026AnsweredUIN 126040More
Question: To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of complaints and accountability processes for NHS patients referred to private healthcare providers.
Answer: The Local Authority Social Services and National Health Service Complaints (England) Regulations 2009 set out in law the minimum standards National Health Service organisations, and independent providers of NHS-funded care, must adhere to in respect of th...
Answered 16 Apr 2026
Original Parliament recordKetamine: MisuseDepartment of Health and Social CareTabled 30 Oct 2025AnsweredUIN 86956More
Question: To ask the Secretary of State for Health and Social Care, what estimate the Government has made of the prevalence of ketamine addiction among under 25s; what steps the Government is taking to address ketamine addiction among young people; and what tailore
Answer: The Department takes seriously the risk of ketamine and other drugs to our young people and is working with partners from across the Government to respond to existing and new drug threats and to reduce and prevent the health harms.Ketamine use among child...
Answered 6 Nov 2025
Original Parliament recordSelective Serotonin Reuptake Inhibitors: Labelling and PackagingDepartment of Health and Social CareTabled 10 Oct 2025AnsweredUIN 80726More
Question: To ask the Secretary of State for Health and Social Care, what discussions he has had with Selective Serotonin Reuptake Inhibitors (SSRIs) manufacturers on the effectiveness of the packaging and labelling of SSRIs in warning patients of (a) the associated
Answer: The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that selective serotonin reuptake inhibitor (SSRI) packaging and labelling produced by marketing authorisation holders (MAHs) reflects what is known about the safet...
Answered 20 Oct 2025
Original Parliament recordNHS: ProcurementDepartment of Health and Social CareTabled 29 Aug 2025AnsweredUIN 72575More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the participation of SMEs in the NHS supply chain; and whether he plans to introduce measures to reduce barriers to entry for SMEs in NHS procurement
Answer: Small and medium-size enterprises (SMEs) have a vital role to play in supporting our health service to deliver on its priorities for patients and staff.NHS England is committed to improving its engagement with SME suppliers and helping to make it easier f...
Answered 9 Sept 2025
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →